Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


A study presented at the Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting in America has shown that MS patients of African descent might better benefit from treatment of...

Multiple sclerosis risk is lower in HIV-infected patients, according to a new study.

The association apparently comes from the chronic dampening down of the immune system associated with...

Researchers at Johns Hopkins University in Baltimore say they have found that visual function in multiple sclerosis (MS) patients correlates with cognitive function, suggesting disease severity...

Scientists have for the first time found a gene that can be linked directly to the development of multiple sclerosis (MS).

While about 10 to 15 per cent of MS cases appear to have a...

Researchers at the University of Technology Sydney (UTS) say they are planning to explore the anti-inflammatory potential of a controlled infection by parasitic worms as a way of preventing the...

Data from an extension phase of a Phase III clinical trial claims the biotin MD1003 showed effectiveness over time as a possible treatment of non-active, progressive multiple sclerosis (MS).

...

US patients with multiple sclerosis could soon gain access to a new treatment option after the US Food and Drug Administration approved Biogen and AbbVie's once-monthly, self-administered...

Researchers have discovered a gene involved in deregulation of certain immune cells in multiple sclerosis.

Characterised by the onset of chronic, neurodegenerative damage of the central...

The Russian Ministry of Health has granted Marketing Authorisation to R-Pharm JSC for the development of Glatirat, a drug intended for the treatment of patients with relapsing-remitting multiple...

New evidence suggests a diet mimicking the effects of fasting has health benefits beyond weight loss, with a USC-led study indicating it may reduce symptoms of multiple sclerosis.

...

Pages

Live Chat Software by Click4Assistance UK